Hepatitis C Virus Antibody, CMIA/CLIA in Mumbai
Understanding Hepatitis C Virus Antibody, CMIA/CLIA in Mumbai
What is Hepatitis C Virus Antibody, CMIA/CLIA in Mumbai?
A Hepatitis C Virus Antibody, CMIA/CLIA test is used to detect the presence of antibodies that the body makes against the hepatitis C virus (HCV) in a person's blood. This test plays a crucial role in screening for HCV infection. It helps determine whether an individual has a current, recent (acute), or past hepatitis C infection.
What does Hepatitis C Virus Antibody, CMIA/CLIA measure?
A Hepatitis C Virus Antibody, CMIA/CLIA test determines the status of a current hepatitis C virus (HCV) infection or past HCV infection that has been resolved. This test, therefore, helps your doctor to guide an appropriate treatment plan. HCV causes liver inflammation and is classified into acute hepatitis infection and chronic hepatitis infection.
-
Acute hepatitis C: This occurs in the first six months after exposure to the hepatitis C virus. In the early stage of the infection, acute hepatitis C is mild and may cause no symptoms. For this reason, most people do not know they have this infection.
-
Chronic hepatitis C: If your body is unable to fight off the virus, you can develop a chronic hepatitis C infection. Progression from acute to chronic hepatitis C is common, occurring in about 75-85% of patients. Detecting chronic hepatitis C at the early stage is important to prevent future complications, such as liver failure, and initiate effective treatment.